Mylan Now Selling Generic Antipsychotic Clozaril
From Associated Press (April 19, 2010)
PITTSBURGH -- Mylan Inc. said Monday it began selling additional doses of the generic from of Novartis AG’s antipsychotic drug Clozaril.
The drug maker said it is now selling 50 milligram and 200 milligram doses of Clozaril, or clozapine tablets. U.S. sales of those doses totaled $13.5 million in 2009. Mylan already sells 25 and 100-milligram doses of generic clozapine.
Mylan also said it received Food and Drug Administration clearance on a generic version of the HIV drug Videx, which is made by Bristol-Myers Squibb Co. The drug is also called didanosine. The FDA approval covers doses of 125, 200, 250 and 400 milligrams. The company said sales of those doses totaled $29 million in 2009.
Shares of Mylan lost a penny to $21.74 in morning trading.
Posted: April 2010